6XBG image
Entry Detail
PDB ID:
6XBG
Title:
Crystal structure of the SARS-CoV-2 (COVID-19) main protease in complex with inhibitor UAW246
Biological Source:
PDB Version:
Deposition Date:
2020-06-05
Release Date:
2020-06-17
Method Details:
Experimental Method:
Resolution:
1.45 Å
R-Value Free:
0.20
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:3C-like proteinase
Chain IDs:A, B
Chain Length:308
Number of Molecules:2
Biological Source:Severe acute respiratory syndrome coronavirus 2
Polymer Type:polypeptide(L)
Description:inhibitor UAW246
Chain IDs:C, D (auth: E)
Chain Length:4
Number of Molecules:2
Biological Source:synthetic construct
Peptide-like Molecules
PRD_002392
Primary Citation
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M pro and cathepsin L.
Sci Adv 6 ? ? (2020)
PMID: 33158912 DOI: 10.1126/sciadv.abe0751

Abstact

The main protease (Mpro) of SARS-CoV-2 is a key antiviral drug target. While most Mpro inhibitors have a γ-lactam glutamine surrogate at the P1 position, we recently found that several Mpro inhibitors have hydrophobic moieties at the P1 site, including calpain inhibitors II and XII, which are also active against human cathepsin L, a host protease that is important for viral entry. In this study, we solved x-ray crystal structures of Mpro in complex with calpain inhibitors II and XII and three analogs of GC-376 The structure of Mpro with calpain inhibitor II confirmed that the S1 pocket can accommodate a hydrophobic methionine side chain, challenging the idea that a hydrophilic residue is necessary at this position. The structure of calpain inhibitor XII revealed an unexpected, inverted binding pose. Together, the biochemical, computational, structural, and cellular data presented herein provide new directions for the development of dual inhibitors as SARS-CoV-2 antivirals.

Legend

Protein

Chemical

Disease

Primary Citation of related structures